215 related articles for article (PubMed ID: 1918981)
21. Ricin-mediated cell-lysis and apoptosis of drug sensitive and resistant tumor-cells.
Morimoto H; Bonavida B
Int J Oncol; 1993 Mar; 2(3):363-71. PubMed ID: 21573563
[TBL] [Abstract][Full Text] [Related]
22. Adriamycin sensitizes the adriamycin-resistant 8226/Dox40 human multiple myeloma cells to Apo2L/tumor necrosis factor-related apoptosis-inducing ligand-mediated (TRAIL) apoptosis.
Jazirehi AR; Ng CP; Gan XH; Schiller G; Bonavida B
Clin Cancer Res; 2001 Dec; 7(12):3874-83. PubMed ID: 11751478
[TBL] [Abstract][Full Text] [Related]
23. Cytotoxic activity of synthetic aza alkyl lysophospholipids against drug sensitive and drug resistant human tumor cell lines.
Morimoto H; Broquet C; Principe P; Mencia-Huerta JM; Braquet P; Bonavida B
Anticancer Res; 1991; 11(6):2223-9. PubMed ID: 1776863
[TBL] [Abstract][Full Text] [Related]
24. The immunocytokine scFv23/TNF targeting HER-2/neu induces synergistic cytotoxic effects with 5-fluorouracil in TNF-resistant pancreatic cancer cell lines.
Lyu MA; Kurzrock R; Rosenblum MG
Biochem Pharmacol; 2008 Feb; 75(4):836-46. PubMed ID: 18082672
[TBL] [Abstract][Full Text] [Related]
25. Epidermal growth factor receptor expression and function control cytotoxic responsiveness to tumor necrosis factor in ME-180 squamous carcinoma cells.
Donato NJ; Yan DH; Hung MC; Rosenblum MG
Cell Growth Differ; 1993 May; 4(5):411-9. PubMed ID: 8518234
[TBL] [Abstract][Full Text] [Related]
26. Modulation of vindesine and doxorubicin resistance in multidrug-resistant pleural mesothelioma cells by tumor necrosis factor-alpha.
Licht T; Lübbert M; Martens C; Bross KJ; Fiebig HH; Mertelsmann R; Herrmann F
Cytokines Mol Ther; 1995 Jun; 1(2):123-32. PubMed ID: 9384669
[TBL] [Abstract][Full Text] [Related]
27. Sensitization of tumor cells to tumor necrosis factor action by the protein kinase inhibitor staurosporine.
Beyaert R; Vanhaesebroeck B; Heyninck K; Boone E; De Valck D; Schulze-Osthoff K; Haegeman G; Van Roy F; Fiers W
Cancer Res; 1993 Jun; 53(11):2623-30. PubMed ID: 8495426
[TBL] [Abstract][Full Text] [Related]
28. Sensitization of human bladder cancer cells to Fas-mediated cytotoxicity by cis-diamminedichloroplatinum (II).
Mizutani Y; Yoshida O; Bonavida B
J Urol; 1998 Aug; 160(2):561-70. PubMed ID: 9679929
[TBL] [Abstract][Full Text] [Related]
29. Diphtheria toxin- and Pseudomonas A toxin-mediated apoptosis. ADP ribosylation of elongation factor-2 is required for DNA fragmentation and cell lysis and synergy with tumor necrosis factor-alpha.
Morimoto H; Bonavida B
J Immunol; 1992 Sep; 149(6):2089-94. PubMed ID: 1517572
[TBL] [Abstract][Full Text] [Related]
30. Rapid induction of apoptosis by combination of flavopiridol and tumor necrosis factor (TNF)-alpha or TNF-related apoptosis-inducing ligand in human cancer cell lines.
Kim DM; Koo SY; Jeon K; Kim MH; Lee J; Hong CY; Jeong S
Cancer Res; 2003 Feb; 63(3):621-6. PubMed ID: 12566305
[TBL] [Abstract][Full Text] [Related]
31. Gene-specific repair of Pt/DNA lesions and induction of apoptosis by the oral platinum drug JM216 in three human ovarian carcinoma cell lines sensitive and resistant to cisplatin.
O'Neill CF; Koberle B; Masters JR; Kelland LR
Br J Cancer; 1999 Dec; 81(8):1294-303. PubMed ID: 10604725
[TBL] [Abstract][Full Text] [Related]
32. Synergistic interactions between tumor necrosis factor and inhibitors of DNA topoisomerase I and II.
Baloch Z; Cohen S; Coffman FD
J Immunol; 1990 Nov; 145(9):2908-13. PubMed ID: 2170526
[TBL] [Abstract][Full Text] [Related]
33. Cytolysis of tumor necrosis factor (TNF)-resistant tumor targets. Differential cytotoxicity of monocytes activated by the interferons, IL-2, and TNF.
Philip R
J Immunol; 1988 Feb; 140(4):1345-9. PubMed ID: 2449501
[TBL] [Abstract][Full Text] [Related]
34. Synergistic induction of apoptosis by the combination of trail and chemotherapy in chemoresistant ovarian cancer cells.
Cuello M; Ettenberg SA; Nau MM; Lipkowitz S
Gynecol Oncol; 2001 Jun; 81(3):380-90. PubMed ID: 11371126
[TBL] [Abstract][Full Text] [Related]
35. Induction of endothelial cell apoptosis by TNF alpha: modulation by inhibitors of protein synthesis.
Polunovsky VA; Wendt CH; Ingbar DH; Peterson MS; Bitterman PB
Exp Cell Res; 1994 Oct; 214(2):584-94. PubMed ID: 7925652
[TBL] [Abstract][Full Text] [Related]
36. Natural killer-sensitive targets stimulate production of TNF-alpha but not TNF-beta (lymphotoxin) by highly purified human peripheral blood large granular lymphocytes.
Peters PM; Ortaldo JR; Shalaby MR; Svedersky LP; Nedwin GE; Bringman TS; Hass PE; Aggarwal BB; Herberman RB; Goeddel DV
J Immunol; 1986 Oct; 137(8):2592-8. PubMed ID: 3760569
[TBL] [Abstract][Full Text] [Related]
37. Induction and regulation of tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand-mediated apoptosis in renal cell carcinoma.
Griffith TS; Fialkov JM; Scott DL; Azuhata T; Williams RD; Wall NR; Altieri DC; Sandler AD
Cancer Res; 2002 Jun; 62(11):3093-9. PubMed ID: 12036919
[TBL] [Abstract][Full Text] [Related]
38. [Anti-tumor effect of human recombinant TNF].
Watanabe N; Niitsu Y; Neda H; Yamauchi N; Maeda M; Kuriyama H; Sone H
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):780-7. PubMed ID: 3291772
[TBL] [Abstract][Full Text] [Related]
39. In vitro selection of a cell line for resistance to lysis by tumor necrosis factor-alpha selects for reduced tumorigenicity.
Patek PQ; Lin Y
J Immunol; 1991 May; 146(10):3457-61. PubMed ID: 2026874
[TBL] [Abstract][Full Text] [Related]
40. Interleukin 1, interleukin 6, tumor necrosis factor, and transforming growth factor beta increase cell resistance to tumor necrosis factor cytotoxicity by growth arrest in the G1 phase of the cell cycle.
Belizario JE; Dinarello CA
Cancer Res; 1991 May; 51(9):2379-85. PubMed ID: 2015601
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
